Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.

Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC.

PMID:
30216086
2.

Between-Visit Variability in FEV1 as a Diagnostic Test for Asthma in Adults.

Dean BW, Birnie EE, Whitmore GA, Vandemheen KL, Boulet LP, FitzGerald JM, Ainslie M, Gupta S, Lemiere C, Field SK, McIvor RA, Hernandez P, Mayers I, Aaron SD; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2018 Sep;15(9):1039-1046. doi: 10.1513/AnnalsATS.201803-211OC.

PMID:
29877740
3.

Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report.

Field SK, Escalante P, Fisher DA, Ireland B, Irwin RS; CHEST Expert Cough Panel.

Chest. 2018 Feb;153(2):467-497. doi: 10.1016/j.chest.2017.11.018. Epub 2017 Nov 28.

PMID:
29196066
4.

Congenital tuberculosis in an extremely preterm infant conceived after in vitro fertilization: case report.

Samedi V, Field SK, Al Awad E, Ratcliffe G, Yusuf K.

BMC Pregnancy Childbirth. 2017 Feb 20;17(1):66. doi: 10.1186/s12884-017-1256-1.

5.

Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta.

Lim R, Jarand J, Field SK, Fisher D.

Can Respir J. 2016;2016:8249843. doi: 10.1155/2016/8249843. Epub 2016 Dec 29.

6.

Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma.

Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Mulpuru S, Alvarez GG, Pakhale S, Mallick R, Boulet LP; Canadian Respiratory Research Network.

JAMA. 2017 Jan 17;317(3):269-279. doi: 10.1001/jama.2016.19627.

PMID:
28114551
7.

Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report.

Kahrilas PJ, Altman KW, Chang AB, Field SK, Harding SM, Lane AP, Lim K, McGarvey L, Smith J, Irwin RS; CHEST Expert Cough Panel.

Chest. 2016 Dec;150(6):1341-1360. doi: 10.1016/j.chest.2016.08.1458. Epub 2016 Sep 7.

8.

Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.

Jarand J, Davis JP, Cowie RL, Field SK, Fisher DA.

Chest. 2016 May;149(5):1285-93. doi: 10.1378/chest.15-0543. Epub 2016 Jan 12.

PMID:
26513209
9.

Fibrosing Bronchiolitis Evolving from Infectious or Inhalational Acute Bronchiolitis. A Reversible Lesion.

Ryerson CJ, Olsen SR, Carlsten C, Donagh C, Bilawich AM, Field SK, Churg A.

Ann Am Thorac Soc. 2015 Sep;12(9):1323-7. doi: 10.1513/AnnalsATS.201504-234BC.

PMID:
26153612
10.

Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?

Field SK.

Ther Adv Chronic Dis. 2015 Jul;6(4):170-84. doi: 10.1177/2040622315582325. Review.

11.

Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel Report.

Vertigan AE, Murad MH, Pringsheim T, Feinstein A, Chang AB, Newcombe PA, Rubin BK, McGarvey LP, Weir K, Altman KW, Weinberger M, Irwin RS, Adams TM, Altman KW, Barker AF, Birring SS, Blackhall F, Bolser DC, Boulet LP, Braman SS, Brightling C, Callahan-Lyon P, Canning BJ, Chang AB, Coeytaux R, Cowley T, Davenport P, Diekemper RL, Ebihara S, El Solh AA, Escalante P, Feinstein A, Field SK, Fisher D, French CT, Gibson P, Gold P, Gould MK, Grant C, Harding SM, Harnden A, Hill AT, Irwin RS, Kahrilas PJ, Keogh KA, Lane AP, Lim K, Malesker MA, Mazzone P, Mazzone S, McCrory DC, McGarvey L, Molasiotis A, Murad MH, Newcombe P, Nguyen HQ, Oppenheimer J, Prezant D, Pringsheim T, Restrepo MI, Rosen M, Rubin B, Ryu JH, Smith J, Tarlo SM, Vertigan AE, Wang G, Weinberger M, Weir K, Wiener RS; CHEST Expert Cough Panel.

Chest. 2015 Jul;148(1):24-31. doi: 10.1378/chest.15-0423. Review.

12.

Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report.

French CT, Diekemper RL, Irwin RS, Adams TM, Altman KW, Barker AF, Birring SS, Blackhall F, Bolser DC, Boulet LP, Braman SS, Brightling C, Callahan-Lyon P, Canning BJ, Chang AB, Coeytaux R, Cowley T, Davenport P, Diekemper RL, Ebihara S, El Solh AA, Escalante P, Feinstein A, Field SK, Fisher D, French CT, Gibson P, Gold P, Gould MK, Grant C, Harding SM, Harnden A, Hill AT, Irwin RS, Kahrilas PJ, Keogh KA, Lane AP, Lim K, Malesker MA, Mazzone P, Mazzone S, McCrory DC, McGarvey L, Molasiotis A, Murad MH, Newcombe P, Nguyen HQ, Oppenheimer J, Prezant D, Pringsheim T, Restrepo MI, Rosen M, Rubin B, Ryu JH, Smith J, Tarlo SM, Vertigan AE, Wang G, Weinberger M, Weir K; CHEST Expert Cough Panel.

Chest. 2015 Jul;148(1):32-54. doi: 10.1378/chest.15-0164. Review.

13.

Embrace simplicity when treating lady windermere.

Jarand J, Field SK.

Chest. 2014 Aug;146(2):244-246. doi: 10.1378/chest.14-0046. No abstract available.

PMID:
25091749
14.

Cytologic assessment of endobronchial ultrasound-guided transbronchial needle aspirates in sarcoidosis.

Chee A, Khalil M, Stather DR, MacEachern P, Field SK, Tremblay A.

J Bronchology Interv Pulmonol. 2012 Jan;19(1):24-8. doi: 10.1097/LBR.0b013e3182442925.

PMID:
23207259
15.

TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial.

Aaron SD, Vandemheen KL, Maltais F, Field SK, Sin DD, Bourbeau J, Marciniuk DD, FitzGerald JM, Nair P, Mallick R.

Thorax. 2013 Feb;68(2):142-8. doi: 10.1136/thoraxjnl-2012-202432. Epub 2012 Nov 17.

PMID:
23161645
16.

New treatment options for multidrug-resistant tuberculosis.

Field SK, Fisher D, Jarand JM, Cowie RL.

Ther Adv Respir Dis. 2012 Oct;6(5):255-68. Epub 2012 Jul 4. Review.

PMID:
22763676
17.

Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations.

Field SK.

Clin Med Insights Circ Respir Pulm Med. 2011;5:57-70. doi: 10.4137/CCRPM.S7049. Epub 2011 Oct 18. Erratum in: Clin Med Insights Circ Respir Pulm Med. 2012;6:51.

18.

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.

Giembycz MA, Field SK.

Drug Des Devel Ther. 2010 Jul 21;4:147-58. Review.

19.

A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction.

Pakhale S, Doucette S, Vandemheen K, Boulet LP, McIvor RA, Fitzgerald JM, Hernandez P, Lemiere C, Sharma S, Field SK, Alvarez GG, Dales RE, Aaron SD.

Chest. 2010 Jun;137(6):1316-23. doi: 10.1378/chest.09-2491. Epub 2010 Feb 12.

PMID:
20154078
20.

Assessment and management of patients with chronic cough by Certified Respiratory Educators: a randomized controlled trial.

Field SK, Conley DP, Thawer AM, Leigh R, Cowie RL.

Can Respir J. 2009 Mar-Apr;16(2):49-54.

21.

Effect of the management of patients with chronic cough by pulmonologists and certified respiratory educators on quality of life: a randomized trial.

Field SK, Conley DP, Thawer AM, Leigh R, Cowie RL.

Chest. 2009 Oct;136(4):1021-1028. doi: 10.1378/chest.08-2399. Epub 2009 Apr 6.

PMID:
19349387
22.

A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis.

Tremblay A, Stather DR, MacEachern P, Khalil M, Field SK.

Chest. 2009 Aug;136(2):340-346. doi: 10.1378/chest.08-2768. Epub 2009 Feb 2.

PMID:
19188547
23.

Overdiagnosis of asthma in obese and nonobese adults.

Aaron SD, Vandemheen KL, Boulet LP, McIvor RA, Fitzgerald JM, Hernandez P, Lemiere C, Sharma S, Field SK, Alvarez GG, Dales RE, Doucette S, Fergusson D; Canadian Respiratory Clinical Research Consortium.

CMAJ. 2008 Nov 18;179(11):1121-31. doi: 10.1503/cmaj.081332. Erratum in: CMAJ. 2008 Dec 2;179(12):1301.

24.

Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma.

Field SK.

Expert Opin Investig Drugs. 2008 May;17(5):811-8. doi: 10.1517/13543784.17.5.811 . Review.

PMID:
18447606
25.

Asthma symptoms do not predict spirometry.

Cowie RL, Underwood MF, Field SK.

Can Respir J. 2007 Sep;14(6):339-42.

26.

Lung disease due to the more common nontuberculous mycobacteria.

Field SK, Cowie RL.

Chest. 2006 Jun;129(6):1653-72. Review.

PMID:
16778288
27.

Extraesophageal manifestations of gastroesophageal reflux.

Field SK, Field TS, Cowie RL.

Minerva Gastroenterol Dietol. 2001 Sep;47(3):137-50.

PMID:
16493371
28.

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial.

Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, Illueca M, Beckman O, Sostek MB.

Am J Respir Crit Care Med. 2006 May 15;173(10):1091-7. Epub 2005 Dec 15.

PMID:
16357331
29.

Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility.

Yang H, Field SK, Fisher DA, Cowie RL.

Int J Tuberc Lung Dis. 2005 Mar;9(3):288-93.

PMID:
15786892
30.

Inhaled corticosteroid therapy does not control asthma.

Cowie RL, Underwood MF, Field SK.

Can Respir J. 2004 Nov-Dec;11(8):555-8.

31.

Mycobacterium avium complex pulmonary disease in patients without HIV infection.

Field SK, Fisher D, Cowie RL.

Chest. 2004 Aug;126(2):566-81. Review.

PMID:
15302746
32.
33.
34.

Is the relationship between obstructive sleep apnea and gastroesophageal reflux clinically important?

Field SK, Flemons WW.

Chest. 2002 Jun;121(6):1730-3. No abstract available.

PMID:
12065328
35.

Tuberculosis in immigrants to Canada. A global problem which requires a global solution.

Cowie RL, Field SK, Enarson DA.

Can J Public Health. 2002 Mar-Apr;93(2):85-7, 91. Review. English, French. No abstract available.

PMID:
11963525
36.

Asthma and gastroesophageal reflux: another piece in the puzzle?

Field SK.

Chest. 2002 Apr;121(4):1024-7. No abstract available.

PMID:
11948028
37.
38.

Gastro-esophageal reflux and asthma.

Field SK, Sutherland LR.

Thorax. 2001 Nov;56(11):898. No abstract available.

40.

Predicting emergency department utilization in adults with asthma: a cohort study.

Cowie RL, Underwood MF, Revitt SG, Field SK.

J Asthma. 2001 Apr;38(2):179-84.

PMID:
11321689
41.

Gastroesophageal reflux and asthma: can the paradox be explained?

Field SK.

Can Respir J. 2000 Mar-Apr;7(2):167-76. Review.

42.

Gastroesophageal reflux and asthma: are they related?

Field SK.

J Asthma. 1999 Dec;36(8):631-44. Review.

PMID:
10609618
43.

Gastroesophageal reflux and respiratory symptoms.

Field SK.

Chest. 1999 Sep;116(3):843. No abstract available.

PMID:
10492302
44.

The effects of antireflux surgery on asthmatics with gastroesophageal reflux.

Field SK, Gelfand GA, McFadden SD.

Chest. 1999 Sep;116(3):766-74. Review.

PMID:
10492285
45.

Omeprazole for asthma with gastro-oesophageal reflux.

Field SK.

Eur Respir J. 1999 Jun;13(6):1495. No abstract available.

46.

Omeprazole in asthma.

Field SK.

Am J Gastroenterol. 1999 Mar;94(3):855-6. No abstract available.

PMID:
10086684
49.

The effects of acid perfusion of the esophagus on ventilation and respiratory sensation.

Field SK, Evans JA, Price LM.

Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1058-62.

PMID:
9563719
50.

The effect of a peak flow-based action plan in the prevention of exacerbations of asthma.

Cowie RL, Revitt SG, Underwood MF, Field SK.

Chest. 1997 Dec;112(6):1534-8.

PMID:
9404750

Supplemental Content

Loading ...
Support Center